Nanopatterned Titanium Implants Accelerate Bone Formation In Vivo.


Journal

ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991

Informations de publication

Date de publication:
29 Jul 2020
Historique:
pubmed: 8 7 2020
medline: 23 2 2021
entrez: 8 7 2020
Statut: ppublish

Résumé

Accelerated de novo formation of bone is a highly desirable aim of implants targeting musculoskeletal injuries. To date, this has primarily been addressed by biologic factors. However, there is an unmet need for robust, highly reproducible yet economic alternative strategies that strongly induce an osteogenic cell response. Here, we present a surface engineering method of translating bioactive nanopatterns from polymeric in vitro studies to clinically relevant material for orthopedics: three-dimensional, large area metal. We use a titanium-based sol-gel whereby metal implants can be engineered to induce osteoinduction both in vitro and in vivo. We show that controlled disordered nanotopographies presented as pillars with 15-25 nm height and 100 nm diameter on titanium dioxide effectively induce osteogenesis when seeded with STRO-1-enriched human skeletal stem cells in vivo subcutaneous implantation in mice. After 28 days, samples were retrieved, which showed a 20-fold increase in osteogenic gene induction of nanopatterned substrates, indicating that the sol-gel nanopatterning method offers a promising route for translation to future clinical orthopedic implants.

Identifiants

pubmed: 32633478
doi: 10.1021/acsami.0c10273
pmc: PMC7467557
doi:

Substances chimiques

Antigens, Surface 0
Coated Materials, Biocompatible 0
Gels 0
STRO-1 antigen, human 0
titanium dioxide 15FIX9V2JP
Titanium D1JT611TNE

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

33541-33549

Subventions

Organisme : Medical Research Council
ID : G1000842
Pays : United Kingdom

Références

Biomol Eng. 2007 Feb;24(1):27-32
pubmed: 16828342
Acta Biomater. 2009 Oct;5(8):3215-23
pubmed: 19447210
J Mater Sci Mater Med. 2008 Nov;19(11):3465-72
pubmed: 18592349
J Mater Sci Mater Med. 2007 Sep;18(9):1863-73
pubmed: 17508132
ACS Nano. 2014 Oct 28;8(10):9941-53
pubmed: 25227207
J Clin Med. 2019 Dec 01;8(12):
pubmed: 31805704
Nat Mater. 2014 Jun;13(6):558-69
pubmed: 24845995
Acta Biomater. 2009 Jun;5(5):1433-41
pubmed: 19208503
Stem Cells. 2009 Sep;27(9):2254-62
pubmed: 19522015
J Surg Oncol. 2020 Mar;121(4):638-644
pubmed: 31989655
Biomaterials. 2004 Jan;25(1):77-83
pubmed: 14580911
Nat Mater. 2007 Dec;6(12):997-1003
pubmed: 17891143
JAMA. 1996 Mar 20;275(11):858-65
pubmed: 8596224
Nano Lett. 2007 Jun;7(6):1686-91
pubmed: 17503870
Lancet. 2007 Oct 27;370(9597):1508-19
pubmed: 17964352
Acta Biomater. 2008 May;4(3):553-9
pubmed: 18207469
Mater Sci Eng C Mater Biol Appl. 2013 Jul 1;33(5):2752-6
pubmed: 23623092
Nanomedicine. 2010 Oct;6(5):619-33
pubmed: 20138244
Biomaterials. 2011 Oct;32(30):7403-10
pubmed: 21820172
Lab Chip. 2008 Apr;8(4):516-8
pubmed: 18369504
Biomaterials. 2009 Sep;30(25):4053-62
pubmed: 19464052
Biomater Sci. 2013 Feb 3;1(2):135-151
pubmed: 32481794
ACS Appl Mater Interfaces. 2012 Nov;4(11):6354-61
pubmed: 23138392
Adv Healthc Mater. 2013 Sep;2(9):1285-93
pubmed: 23495107
Biomaterials. 2009 Oct;30(28):5094-103
pubmed: 19539986
Nanoscale. 2017 Nov 30;9(46):18129-18152
pubmed: 29143002
Histochem J. 1979 Jul;11(4):447-55
pubmed: 91593

Auteurs

Andrew I M Greer (AIM)

Division of Biomedical Engineering, School of Engineering, University of Glasgow, GlasgowG12 8LT, United Kingdom.

Vitali Goriainov (V)

Bone and Joint Research Group, Centre for Human Development Stem Cells and Regeneration, University of Southampton, Southampton SO16 6YD, United Kingdom.

Janos Kanczler (J)

Bone and Joint Research Group, Centre for Human Development Stem Cells and Regeneration, University of Southampton, Southampton SO16 6YD, United Kingdom.

Cameron R M Black (CRM)

Bone and Joint Research Group, Centre for Human Development Stem Cells and Regeneration, University of Southampton, Southampton SO16 6YD, United Kingdom.

Lesley-Anne Turner (LA)

Centre for Cell Engineering, University of Glasgow, Glasgow G12 8QQ, United Kingdom.

Robert M D Meek (RMD)

Department of Orthopaedics, Queen Elizabeth University Hospital, 1345 Govan Road, Glasgow, Lanarkshire G51 4TF, United Kingdom.

Karl Burgess (K)

Glasgow Polyomics Facility, Institute of Biomedical and Life Sciences, University of Glasgow, GlasgowG12 8QQ, United Kingdom.

Ian MacLaren (I)

School of Physics, University of Glasgow, Glasgow G12 8QQ, United Kingdom.

Matthew J Dalby (MJ)

Centre for Cell Engineering, University of Glasgow, Glasgow G12 8QQ, United Kingdom.

Richard O C Oreffo (ROC)

Bone and Joint Research Group, Centre for Human Development Stem Cells and Regeneration, University of Southampton, Southampton SO16 6YD, United Kingdom.

Nikolaj Gadegaard (N)

Division of Biomedical Engineering, School of Engineering, University of Glasgow, GlasgowG12 8LT, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH